The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Effect of intervention through a pharmaceutical care program on patient adherence with prescribed once-daily atorvastatin
Abstract
Aims: Correct execution of prescribed dosing regimen(s) is essential for patients to benefit from lipid lowering treatments. The objective of this study was to estimate the effect of a pharmaceutical care program on the adherence of once‐daily atorvastatin treatment in patients with elevated cholesterol levels. Methods: In both linguistic regions of Belgium, two districts were randomized between usual care and a supportive intervention program. Eligible patients included hyperlipemic subjects taking atorvastatin for at least 3 months. ‘Adherence’ was defined as the proportion of days during which the electronic device record showed that the patient had taken the daily dose. ‘Persistence’ quantifies how long the treatment is executed. Results: A total of 392 patients from 35 pharmacies were included in the intent‐to‐treat (ITT) analysis of the data (194 patients received intervention and 198 in the control group). The intervention resulted in a 6.5% increase in post‐baseline adherence (p < 0.001) mainly driven by a 13% increase in persistence at 1 year (p = 0.002). Conclusion: A supportive pharmaceutical care program consisting of review by patient and pharmacist of each patient's electronically compiled dosing history, plus educational reminders, improves patient adherence to the once‐daily atorvastatin dosing regimen, mainly by extending persistence. Copyright © 2005 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Adherence was significantly higher in the intervention group (87%) compared to the control group (74%) (P = 0.002)”
From Interventions to improve adherence among patients prescribed statins for primary prevention of cardiovascular diseases: a systematic review and meta-analysis (2026) · cites this paper as Vrijens et al., 2006
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Second Joint Task Force of European (1998) · European Heart Journal · doi:10.1053/euhj.1998.1243 · Cited by 1,131
Learning versus confirming in clinical drug development*
Sheiner, L. B. (1997) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(97)90160-0 · Cited by 633
Research works printed but not linked: 7
- The Lipid Research Clinics Coronary Primary Prevention Trial results: (I), 1984, Reduction in incidence of coronary heart disease; (II) The relationship of reduction in incidence of coronary heart disease to cholesterol lowering, JAMA, 251, 351
- 10.1046/j.1524-4733.2000.36006.x · DOI
- 10.1001/jama.288.4.455 · DOI · Paper page
- 10.1016/S0140-6736(03)12948-0 · DOI · Paper page
- Scandinavian Simvastatin Survival Study Group, 1994, Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S), Lancet, 344, 1383
- 10.1001/jama.1989.03420220087032 · doi:10.1001/jama.1989.03420220087032 · Paper page
- 10.1016/S0197-2456(00)00088-X · DOI
Cited by
Vrijens, B., Vincze, G., Kristanto, P., Urquhart, J., & Burnier, M. (2008) · BMJ · doi:10.1136/bmj.39553.670231.25 · Cited by 863
Self-citationBlaschke, T. F., Osterberg, L., Vrijens, B., & Urquhart, J. (2012) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011711-113247 · Cited by 419
Self-citationMachado, M., Bajcar, J., Guzzo, G. C., & Einarson, T. R. (2007) · Annals of Pharmacotherapy · doi:10.1345/aph.1k311 · Cited by 378
Effect of outpatient pharmacists' non-dispensing roles on patient outcomes and prescribing patterns
Nkansah, N., Mostovetsky, O., Yu, C., Chheng, T., Beney, J., Bond, C. M., & Bero, L. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000336.pub2 · Cited by 343
Interventions to improve adherence to lipid-lowering medication
van Driel, M. L., Morledge, M. D., Ulep, R., Shaffer, J. P., Davies, P., & Deichmann, R. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004371.pub4 · Cited by 333
Metadata
- Authors
- Vrijens, B., Belmans, A., Matthys, K., Klerk, E. D., & Lesaffre, E.
- Venue
- Pharmacoepidemiology and Drug Safety
- Publisher
- Wiley
- Published
- 2005-12-12
- Volume
- 15
- Issue
- 2
- Pages
- 115-121
- ISSN
- 1053-8569
- 1099-1557
- Cited by
- 62
- References
- 2
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.